Related Experiment Video
Updated: Aug 20, 2026

Bacterial Expression and Purification of Human Matrix Metalloproteinase-3 using Affinity Chromatography
Published on: March 30, 2022
Elevated matrix metalloproteinase-9 in patients with systemic sclerosis
Wan-Uk Kim1, So-Youn Min, Mi-La Cho
1Division of Rheumatology, Department of Internal Medicine, Catholic Research Institutes of Medical Science, School of Medicine, The Catholic University of Korea, Seoul, Republic of Korea. wan725@catholic.ac.kr
Abstract:
Matrix metalloproteinase-9 (MMP-9) has been implicated in the pathogenesis of cancer, autoimmune disease, and various pathologic conditions characterized by excessive fibrosis. In this study, we investigated the expression of MMP-9 and its clinical significance in systemic sclerosis (SSc). The patients (n = 42) with SSc had higher concentrations of MMP-9 and of tissue inhibitor of metalloproteinase-1 (TIMP-1) and a higher ratio of MMP-9 to TIMP-1 in sera than healthy controls (n = 32). Serum MMP-9 concentrations were significantly higher in the diffuse type (n = 23) than the limited type of SSc (n = 19). Serum concentrations of MMP-9 correlated well with the degree of skin involvement, as determined by the Rodnan score and with serum concentrations of transforming growth factor beta. Moreover, dermal fibroblasts from patients with SSc produced more MMP-9 than those from healthy controls when they were stimulated with IL-1beta, tumor necrosis factor alpha, or transforming growth factor beta. Such an increase in MMP-9 production was partially blocked by treatment with cyclosporin A. In summary, the serum MMP-9 concentrations were elevated in SSc patients and correlated well with skin scores. The increased MMP-9 concentrations may be attributable to overproduction by dermal fibroblasts in SSc. These findings suggest that the enhanced production of MMP-9 may contribute to fibrogenic remodeling during the progression of skin sclerosis in SSc.
Insights
Matrix metalloproteinase-9 (MMP-9) is elevated in systemic sclerosis (SSc) patients, correlating with skin scores. Increased MMP-9 from dermal fibroblasts may drive fibrotic remodeling in SSc.
Area of Science:
- Biochemistry
- Immunology
- Dermatology
Background:
- Matrix metalloproteinase-9 (MMP-9) is linked to fibrosis in various diseases.
- Systemic sclerosis (SSc) is a fibrotic autoimmune condition with unclear pathogenesis.
- Investigating MMP-9 in SSc may reveal therapeutic targets.
Purpose of the Study:
- To examine MMP-9 expression and its clinical significance in systemic sclerosis (SSc).
- To determine if MMP-9 levels correlate with disease severity and specific SSc subtypes.
- To investigate the source of elevated MMP-9 in SSc patients.
Main Methods:
- Serum samples from SSc patients (n=42) and healthy controls (n=32) were analyzed for MMP-9 and TIMP-1 concentrations.
- MMP-9 levels were compared between diffuse and limited SSc subtypes.
- Correlations between serum MMP-9 and clinical parameters (Rodnan score, TGF-β) were assessed.
- Dermal fibroblasts from SSc patients and controls were stimulated with cytokines (IL-1β, TNF-α, TGF-β) to measure MMP-9 production.
- The effect of cyclosporin A on MMP-9 production was evaluated.
Main Results:
- SSc patients exhibited higher serum MMP-9 and TIMP-1 concentrations and a higher MMP-9/TIMP-1 ratio compared to controls.
- Serum MMP-9 levels were significantly elevated in the diffuse SSc subtype compared to the limited subtype.
- Serum MMP-9 concentrations positively correlated with the Rodnan skin score and serum TGF-β levels.
- SSc dermal fibroblasts produced more MMP-9 than control fibroblasts upon cytokine stimulation.
- Cyclosporin A partially inhibited the increased MMP-9 production by SSc fibroblasts.
Conclusions:
- Elevated serum MMP-9 concentrations are characteristic of systemic sclerosis.
- Increased MMP-9 levels in SSc correlate with disease severity, particularly skin involvement.
- Dermal fibroblasts are a likely source of elevated MMP-9 in SSc, potentially contributing to fibrotic processes.
- MMP-9 represents a potential therapeutic target for managing fibrotic remodeling in SSc.
Related Concept Videos
Role of Matrix Metalloproteases in Degradation of ECM
A...
Extracellular Matrix
The Extracellular Matrix
In order to maintain tissue organization, many animal cells are surrounded by structural molecules that make up the extracellular matrix (ECM). Together, the molecules in the ECM maintain the structural integrity of tissue as well as the remarkable specific properties of certain tissues.
Composition of the Extracellular Matrix
The extracellular matrix (ECM) is commonly composed of ground substance, a gel-like fluid, fibrous components, and many structurally and functionally diverse...
The Extracellular Matrix